Dr Natalie Gauld is a pharmacist and reclassification consultant at Natalie Gauld Ltd. She is an Honorary Research Fellow at the Department of General Practice and Primary Health Care, University of Auckland, New Zealand. She has received funding for reclassifications including trimethoprim, vaccinations, calcipotriol, adapalene, sildenafil and oral contraceptives. She was on the Medicines Classification Committee in NZ (2004-2009). She has consulted to Green Cross Health, the pharmaceutical industry and pharmacy organisations. She has received travel funding for speaking engagements at conferences from industry and pharmacy organisations. She received unrestricted research grants from Green Cross Health, the Pharmacy Guild, the Pharmaceutical Society of NZ and ProPharma for the trimethoprim research. She is a member of the National Executive of the Pharmaceutical Society of NZ. The opinions expressed in this article are the author’s, and not as a representative of any organisation.